James Woodruff Lillie

CIK: 0001728746

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)21 (84.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (12.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (4.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MPLT

MapLight Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (25 total)

MPLT
MapLight Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
11.5K shares at avg. $8.08$93K
MPLT
MapLight Therapeutics, Inc.
Aug 17, 2026
Award(A)
Direct
7.7K shares-
MPLT
MapLight Therapeutics, Inc.
Aug 3, 2026
Sale(S)
Direct
22.1K shares at avg. $12.54$277K
MPLT
MapLight Therapeutics, Inc.
Jul 17, 2026
Sale(S)
Direct
2.1K shares at avg. $37.90$79K
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
12 shares at avg. $37.96$455.52
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
3.5K shares at avg. $37.26$131K
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
5K shares at avg. $36.45$183K
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
12 shares at avg. $37.54$450.48
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
5.4K shares at avg. $36.99$199K
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
2.2K shares at avg. $36.00$81K
MPLT
MapLight Therapeutics, Inc.
May 7, 2026
Sale(S)
Direct
721 shares at avg. $28.28$20K
MPLT
MapLight Therapeutics, Inc.
May 6, 2026
Sale(S)
Direct
8.4K shares at avg. $28.04$235K
MPLT
MapLight Therapeutics, Inc.
May 6, 2026
Sale(S)
Direct
16.4K shares at avg. $29.13$478K
MPLT
MapLight Therapeutics, Inc.
May 5, 2026
Sale(S)
Direct
963 shares at avg. $29.00$28K
MPLT
MapLight Therapeutics, Inc.
May 5, 2026
Sale(S)
Direct
10.1K shares at avg. $28.12$285K
MPLT
MapLight Therapeutics, Inc.
May 4, 2026
Sale(S)
Direct
9.3K shares at avg. $27.50$254K
MPLT
MapLight Therapeutics, Inc.
May 4, 2026
Sale(S)
Direct
705 shares at avg. $30.08$21K
MPLT
MapLight Therapeutics, Inc.
May 4, 2026
Sale(S)
Direct
320 shares at avg. $29.56$9K
MPLT
MapLight Therapeutics, Inc.
May 4, 2026
Sale(S)
Direct
5.5K shares at avg. $28.37$157K
MPLT
MapLight Therapeutics, Inc.
Apr 16, 2026
Sale(S)
Direct
2.1K shares at avg. $27.49$58K
MPLT
MapLight Therapeutics, Inc.
Apr 16, 2026
Sale(S)
Direct
686 shares at avg. $27.01$19K
MPLT
MapLight Therapeutics, Inc.
Apr 15, 2026
Sale(S)
Direct
1.7K shares at avg. $26.82$46K
MPLT
MapLight Therapeutics, Inc.
Feb 5, 2026
Award(A)
Direct
7.7K shares-
MPLT
MapLight Therapeutics, Inc.
Jan 27, 2026
Tax Payment(F)
Direct
45.1K shares at avg. $17.98$810K
MPLT
MapLight Therapeutics, Inc.
Oct 27, 2025
Award(A)
Direct
32.5K shares-

		Type	Shares	Price		Ownership
Oct 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	11,513	$8.08	$93,025	Direct
Aug 17, 2026	MPLT MapLight Therapeutics, Inc.	Award(A)	7,730	-	$0	Direct
Aug 3, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	22,082	$12.54	$276,908	Direct
Jul 17, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	2,077	$37.90	$78,718	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	12	$37.96	$456	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	3,526	$37.26	$131,379	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,009	$36.45	$182,578	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	12	$37.54	$450	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,393	$36.99	$199,487	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	2,238	$36.00	$80,568	Direct
May 7, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	721	$28.28	$20,390	Direct
May 6, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	8,390	$28.04	$235,256	Direct
May 6, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	16,421	$29.13	$478,344	Direct
May 5, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	963	$29.00	$27,927	Direct
May 5, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	10,132	$28.12	$284,912	Direct
May 4, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	9,250	$27.50	$254,375	Direct
May 4, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	705	$30.08	$21,206	Direct
May 4, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	320	$29.56	$9,459	Direct
May 4, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,526	$28.37	$156,773	Direct
Apr 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	2,097	$27.49	$57,647	Direct
Apr 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	686	$27.01	$18,529	Direct
Apr 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	1,730	$26.82	$46,399	Direct
Feb 5, 2026	MPLT MapLight Therapeutics, Inc.	Award(A)	7,730	-	$0	Direct
Jan 27, 2026	MPLT MapLight Therapeutics, Inc.	Tax Payment(F)	45,055	$17.98	$810,089	Direct
Oct 27, 2025	MPLT MapLight Therapeutics, Inc.	Award(A)	32,539	-	-	Direct

1-25 of 25 transactions

About Lillie James Woodruff

Lillie James Woodruff (SEC CIK 0001728746) files insider reports with the SEC as Chief Scientific Officer of MapLight Therapeutics, Inc. (MPLT).

Signal8 holds 11 ownership filings by Lillie James Woodruff (1 Form 3, 10 Form 4), filed between Oct 27, 2025 and Oct 16, 2026. Those filings report 25 transactions, from Oct 27, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lillie James Woodruff's filings is in REDWOOD CITY, CA.

Recent filings by Lillie James Woodruff

Oct 15, 2026: Open-market sale of MPLT shares (Form 4, code S).
Aug 17, 2026: Grant or award of MPLT shares (Form 4, code A).
Aug 3, 2026: Open-market sale of MPLT shares (Form 4, code S).
Jul 17, 2026: Open-market sale of MPLT shares (Form 4, code S).
Jul 16, 2026: Open-market sales of MPLT shares (3 lines, Form 4, code S).

Other insiders filing for MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol, Chief Discovery Officer
GILLIS JONATHAN, CAO and Interim CFO
Hanson Kristopher, General Counsel
Foff Erin Pennock, Chief Medical Officer
Kroeger Christopher A., Chief Executive Officer
Cox Troy, Director

How to read Form 4 transaction codes